Articles related to BIOMARKERS

The multidisciplinary guidelines introduce blood-based biomarkers as key diagnostic tools, potentially reducing unnecessary CT scans while improving outcome predictions.

Nearly half of behavioral variant frontotemporal dementia patients initially receive a psychiatric diagnosis, highlighting the critical need for improved diagnostic approaches.

Changes to blood-based biomarkers can be detected before Alzheimer’s symptoms appear, potentially allowing for earlier intervention and more targeted treatment approaches.

The study found no evidence that any of 25 routine clinical laboratory values provide a reliable biomarker of prior infection, PASC, or specific PASC clusters.

An innovative blood test using artificial intelligence has shown the potential to detect Parkinson’s disease up to seven years before symptoms appear, offering new possibilities for early intervention and treatment.

As physicians, understanding the new biomarker legislation is crucial—it not only shapes insurance coverage but also influences clinical decision-making and patient access to precision medicine, potentially leading to more cost-effective and targeted care.